Cargando…
Monoclonal Antibodies against Nucleocapsid Protein of SARS-CoV-2 Variants for Detection of COVID-19
Mitigation strategies of the coronavirus disease 2019 (COVID-19) pandemic have been greatly hindered by the continuous emergence of SARS-CoV-2 variants. New sensitive, rapid diagnostic tests for the wide-spectrum detection of viral variants are needed. We generated a panel of 41 monoclonal antibodie...
Autores principales: | Lu, Ruei-Min, Ko, Shih-Han, Chen, Wan-Yu, Chang, Yu-Ling, Lin, Hsiu-Ting, Wu, Han-Chung |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8623253/ https://www.ncbi.nlm.nih.gov/pubmed/34830291 http://dx.doi.org/10.3390/ijms222212412 |
Ejemplares similares
-
Antibody cocktail effective against variants of SARS-CoV-2
por: Liang, Kang-Hao, et al.
Publicado: (2021) -
Monoclonal antibodies against S2 subunit of spike protein exhibit broad reactivity toward SARS-CoV-2 variants
por: Ko, Shih-Han, et al.
Publicado: (2022) -
Production and Characterization of Monoclonal Antibodies Against the Nucleocapsid Protein of SARS-COV
por: Fang, Ying, et al.
Publicado: (2006) -
Monoclonal antibodies for COVID-19 therapy and SARS-CoV-2 detection
por: Hwang, Yu-Chyi, et al.
Publicado: (2022) -
Development of SARS-CoV-2 Nucleocapsid Specific Monoclonal Antibodies
por: Terry, James S., et al.
Publicado: (2020)